Clinical Trials in Arizona

Showing 1941-1960 of 8,032 trials

STEM-PD Open Label Extension (OLE)

NCT04799418

This study seeks to establish the safety and efficacy of extended twice daily time-varying caloric vestibular stimulation treatments for treating symptoms associated with Parkinson's disease. Only participants who completed the STEM-PD randomized controlled trial portion (NCT04797611) are eligible to participate in the open label extension portion.

Parkinson DiseaseParkinson's Disease and Parkinsonism

Scion NeuroStim148 participantsStarted Sep 2022

Scottsdale, Arizona, United States • Los Angeles, California, United States • Boca Raton, Florida, United States +12 more locations

COMPLETEDPhase 231 miles

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

NCT04963231

The purpose of this study was to evaluate the safety and efficacy of once daily subcutaneous (SC) administration of setmelanotide in participants with obesity and specific gene variants in the MC4R pathway.

Genetic Obesity

Rhythm Pharmaceuticals, Inc.164 participantsStarted Nov 2021

Scottsdale, Arizona, United States • Suwanee, Georgia, United States • Worcester, Massachusetts, United States +33 more locations

STEM-PD Open Label Extension (OLE)

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

Find Trials by Condition in Arizona

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population

Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households

Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy

Regenerative Medicine Approach to Nasal Reconstruction

Vaginal Ecosystem and Network in the United States Study

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

Predicting Local and Distant Recurrence in T1 Colorectal Cancer

Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study